Form 4 for INSM INSMED Inc
Accepted 2022-01-10 00:00:00 ET · period of report 2022-01-06 · accession 0001140361-22-001162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-10 | 2022-01-06 | INSM | Smith Michael Alexander | GC, Senior VP | A - Grant | — | +9,458 | 37.8K | +33% | — |
| D | 2022-01-10 | 2022-01-06 | INSM | Smith Michael Alexander | GC, Senior VP | A - Grant | $0.00 | +45.7K | 45.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | A | A | 9,458 | — | 37,833 | D | — | — | (F1) Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. (F2) Each Restricted Stock Unit was received as a grant on January 6, 2022, for no consideration. |
| 2 | Derivative | Stock Option (right to buy) | 2022-01-06 | A | A | 45,700 | $0.00 | 45,700 | D | $26.43 · — to 2032-01-06 | 45,700 Common Stock | (F3) Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |